Discover

Back to filter

Related topics

Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles

Spectral Instruments Imaging

Jun 23, 2021

Overactivation of the PI3K/mTOR signaling has been identified in non-Hodgkin’s lymphoma....

Top 10 Pharma companies have chosen CYTEK for their flow cytometry facility

Cytek Biosciences

Jun 21, 2021

6 of Top 10 Pharma Companies (Based on total group revenues) have chosen CYTEK - full...

Elevated NSD3 histone methylation activity drives squamous cell lung cancer

Spectral Instruments Imaging

Jun 8, 2021

This work identifies NSD3 as a principal 8p11-12 amplicon-associated oncogenic driver in...

A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic

Tonbo Biosciences

May 21, 2021

Tonbo Biosciences flow cytometry reagents & antibodies are manufactured with the highest...

IncuCyte webinar recording: How to measure Immune Cell Killing of Tumor Cells effectively

Sartorius

May 19, 2021

Immuno-oncology (IO) has transformed cancer treatment. The number of treatments in the IO...

White Paper: Immunophenotyping Rare Immune Cells with Laminar Wash AUTO System

Curiox

May 18, 2021

The Laminar Wash (LW) AUTO system consists of a wall-less plate and a laminar flow cell...

Show all topics (10)

Fluorescent reagents for in vivo optical imaging

May 26, 2017

Applications for in vivo fluorescent small animal imaging are varied and include cell tracking, tracer/probe development, and detection of molecular biomarkers. These methods have been applied in models of cancer, infection, inflammation, and stem cell biology. The catalogue of fluorescent reagents has expanded significantly in the past decade.
There have been two primary developments in the evolution of in vivo fluorescent reagents during this time (1) red-shifted fluorescent proteins (e.g. tdTomato) and NIR dyes (e.g. Cy7), which are more commonly used for in vivo imaging applications and (2) the range of validated targeted probes, which has expanded significantly.

Bruker Optical/X-ray imaging systems are equipped standard with full multispectral (Yudina et al., 2016) fluorescence VISNIR imaging capability, compatible with most custom and commercial reporters.
Also, Bruker Optical/X-ray imaging systems have been employed with a range of fluorescent reporters including but not limited to YFP, eGFP, mCherry, and many others.

Read more

Scientific paper
Application

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey